FOXO4-DRI mastery course
Unit 8 of 11

Research frontiers & the road to trials

A striking preclinical result is the start of a very long road, not the end.

From a mouse paper to a medicine, if it ever gets there

A striking preclinical result is the start of a very long road, not the end. Turning FOXO4-DRI into an approved therapy would require a developable molecule, pharmacokinetic data of any kind, a safety package, and a first human trial in the right population. This unit maps that road and the gaps along it.

It also gives you a durable tool: a way to judge the next FOXO4-DRI headline that appears, because new papers will keep coming.

Key terms

Where FOXO4-DRI sits on the evidence ladder


Who owns this molecule, and what that means


How a first trial might be designed


The gaps, listed plainly


How to judge the next headline